Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
With the agarose concentrating group of Peiyuan Guben Tongluo Ointment set as the parallel control and an external control established simultaneously, this study aimed to evaluate the increases from baseline in DXA-measured limb muscle mass after 12 weeks of medication in elderly sarcopenia patients treated with the Ejiao concentrating group of Peiyuan Guben Tongluo Ointment.
Epistemonikos ID: d955f93cc42507dcc187b64e80710c38dfa07b71
First added on: Apr 21, 2026